Long-term fat intake and biomarkers, Am, J. Clin. Nutr, vol.61, pp.721-725, 1995. ,
In vivo approaches to quantifying and imaging brain arachidonic and docosahexaenoic acid metabolism, The Journal of Pediatrics, vol.143, issue.4, pp.26-34, 2003. ,
DOI : 10.1067/S0022-3476(03)00399-8
Specificity of expression and effects of eicosanoid mediators in normal physiology and human diseases, FASEB J, vol.9, pp.1051-1058, 1995. ,
Group-Specific Assays That Distinguish between the Four Major Types of Mammalian Phospholipase A2, Analytical Biochemistry, vol.269, issue.2 ,
DOI : 10.1006/abio.1999.4053
A novel arachidonic acid-selective cytosolic PLA2 contains a Ca2+-dependent translocation domain with homology to PKC and GAP, Cell, vol.65, issue.6, pp.1043-1051, 1991. ,
DOI : 10.1016/0092-8674(91)90556-E
Diacylglycerol lipase activity in human platelet intracellular and surface membranes, FEBS Letters, vol.222, issue.1, pp.95-101, 1985. ,
DOI : 10.1016/0014-5793(85)80239-8
Oxidant-induced arachidonic acid release and impairment of fatty acid acylation in vascular smooth muscle cells, Am. J ,
Quantitative studies of hydroperoxide reduction by prostaglandin H synthase. Reducing substrate specificity and the relationship of peroxidase to cyclooxygenase activities, J. Biol. Chem, vol.262, pp.6266-6279, 1987. ,
Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides, Proc. Natl. Acad. Sci. U. S ,
Interactions between prostaglandin E2 and inhibitors of platelet aggregation which act through cyclic AMP, European Journal of Pharmacology, vol.194, issue.1, pp.63-70, 1991. ,
DOI : 10.1016/0014-2999(91)90124-9
Stimulation of human platelet adenylate cyclase by prostaglandin D2, Thrombosis Research, vol.5, issue.3, pp.401-412, 1975. ,
DOI : 10.1016/0049-3848(74)90176-5
Prostanoid Receptors., Annals of the New York Academy of Sciences, vol.267, issue.1 Cellular Gene, pp.1193-1226, 1999. ,
DOI : 10.1016/0014-2999(79)90162-6
Simultaneous determination of prostaglandins (PG) E2, A2 and B2 and stability studies of PGE2 in pharmaceutical preparations by ion-pair reversed phase HPLC ,
Biological activities and mechanisms of action of PGJ2 and related compounds: an update, Prostaglandins, Leukotrienes and Essential Fatty Acids, vol.47, issue.1, pp.1-12, 1992. ,
DOI : 10.1016/0952-3278(92)90178-L
Activation of nuclear receptors by prostaglandins, Thrombosis Research, vol.110, issue.5-6, pp.311-315, 2003. ,
DOI : 10.1016/S0049-3848(03)00418-3
Metabolism of fatty acids by platelets and the functions of various metabolites in mediating platelet function, Progress in Lipid Research, vol.27, issue.2, pp.135-152, 1988. ,
DOI : 10.1016/0163-7827(88)90008-2
Prostaglandin F synthase, Prostaglandins Other Lipid Mediat, pp.68-69, 2002. ,
Hematopoietic prostaglandin D synthase,ProstaglandinsLeukot. Essent. Fat, pp.163-167, 2003. ,
DOI : 10.1016/s0952-3278(03)00077-2
Prostaglandin E synthases: Understanding their pathophysiological roles through mouse genetic models, Biochimie, vol.92, issue.6, pp.651-659, 2010. ,
DOI : 10.1016/j.biochi.2010.02.007
Effects of reduced glutathione on the 12-lipoxygenase pathways in rat platelets, Biochemical Journal, vol.202, issue.3, pp.771-776, 1982. ,
DOI : 10.1042/bj2020771
(S)- Hydroperoxyeicosatetraenoic acid increases arachidonic acid availability in collagen-primed platelets, J. Lipid Res, vol.4, pp.12-1467, 2001. ,
Inhibition by lipoxygenase products of TXA2-like responses of platelets and vascular smooth muscle, Biochemical Pharmacology, vol.37, issue.7, pp.1275-1280, 1988. ,
DOI : 10.1016/0006-2952(88)90782-4
12-HETE inhibits the binding of PGH2/TxA2 receptor ligands in human platelets, Thrombosis Research, vol.63, issue.2, pp.239-248, 1991. ,
DOI : 10.1016/0049-3848(91)90287-7
Redirection of prostaglandin endoperoxide metabolism at the platelet-vascular interface in man., Journal of Clinical Investigation, vol.83, issue.2, pp.380-385, 1989. ,
DOI : 10.1172/JCI113895
Mechanisms involved in the stimulation of prostacyclin synthesis by human lymphocytes in human umbilical vein endothelial cells, British Journal of Pharmacology, vol.157, issue.2, pp.321-328, 2003. ,
DOI : 10.1038/sj.bjp.0705253
Tranylcypromine and 15-hydroperoxyarachidonate affect arachidonic acid release in addition to inhibition of prostacyclin synthesis in calf aortic endothelial cells, J. Biol. Chem, vol.255, pp.9538-9540, 1980. ,
FACTORS REGULATING THE BIOSYNTHESIS OF VARIOUS PROSTAGLANDINS, Annals of the New York Academy of Sciences, vol.3, issue.1 Prostaglandin, pp.107-122, 1971. ,
DOI : 10.1002/anie.196901671
Leukotrienes: Mediators of Allergic Reactions and Inflammation, International Archives of Allergy and Immunology, vol.66, issue.1 ,
DOI : 10.1159/000232880
Leu kotriene A: stereochemistry and enzymatic conversion to leukotriene B4, Biochem. Biophys ,
Comparative biological activities of synthetic leukotriene b4 and its ??-oxidation products, Prostaglandins, vol.25, issue.1, pp.29-37, 1983. ,
DOI : 10.1016/0090-6980(83)90132-6
Studies on the mechanism of formation of the 5S, Prostaglandins, vol.126810, issue.23, pp.14-713, 1982. ,
Stereospecific inhibition of PGH2-induced platelet aggregation by lipoxygenase products of icosaenoic acids, Biochemical and Biophysical Research Communications, vol.112, issue.3, pp.878-883, 1983. ,
DOI : 10.1016/0006-291X(83)91699-6
Poxytrins, a class of oxygenated products from polyunsaturated fatty acids, potently inhibit blood platelet aggregation, The FASEB Journal, vol.25, issue.1, pp.382-388, 2011. ,
DOI : 10.1096/fj.10-161836
URL : https://hal.archives-ouvertes.fr/inserm-00517396
Mac Leod, Effects of oxo and dihydro metabolites of 12-hydroxy-5, acid on chemotaxis and cytosolic calcium levels in human neutrophils, J. Leukoc, p.14 ,
The eosinophil chemoattractant 5-oxo-ETE and the OXE receptor, Progress in Lipid Research, vol.52, issue.4, pp.651-665, 2013. ,
DOI : 10.1016/j.plipres.2013.09.001
Leukotriene A4: Enzymatic conversion to leukotriene C4, Biochemical and Biophysical Research Communications, vol.96, issue.4, pp.1679-1687, 1980. ,
DOI : 10.1016/0006-291X(80)91367-4
Leukotrienes and lipoxins: structures, biosynthesis, and biological effects, Science, vol.237, issue.4819, pp.1171-1176, 1987. ,
DOI : 10.1126/science.2820055
Biosynthesis and metabolism of leukotrienes, Biochem ,
15-Hydroxyprostaglandin dehydrogenase. A review, Prostaglandins, vol.12, issue.4, pp.647-679, 1976. ,
DOI : 10.1016/0090-6980(76)90044-7
Identification of 13,14-dihydro-15-oxo-prostaglandin F2?? in the circulation during infusions of bradykinin and prostaglandin E2 in man, British Journal of Pharmacology, vol.260, issue.1, pp.245-250, 1987. ,
DOI : 10.1111/j.1476-5381.1987.tb09005.x
Identification of metabolites from peroxisomal beta-oxidation of prostaglandins, J. Lipid Res, vol.31, pp.307-314, 1990. ,
??-Oxidation of eicosanoids, Progress in Lipid Research, vol.33, issue.4, pp.403-428, 1994. ,
DOI : 10.1016/0163-7827(94)90025-6
20-Hydroxyeicosatetraenoic Acid (20-HETE) Metabolism in Coronary Endothelial Cells, Journal of Biological Chemistry, vol.279, issue.4, pp.2648-2656, 2004. ,
DOI : 10.1074/jbc.M306849200
Cytochrome P450 and the arachidonate cascade, FASEB J, vol.6, pp.731-736, 1992. ,
Oxygenation of polyunsaturated fatty acids by cytochrome P450 monooxygenates, Progress in Lipid Research, vol.33, issue.3, pp.329-354, 1994. ,
DOI : 10.1016/0163-7827(94)90029-9
Epoxides and Soluble Epoxide Hydrolase in Cardiovascular Physiology, Physiological Reviews, vol.92, issue.1, pp.101-130, 2012. ,
DOI : 10.1152/physrev.00021.2011
Interactions between n-3 and n-6 essential fatty acids (EFAs) in the regulation of cardiovascular disorders and inflammation, Prostaglandins, Leukotrienes and Essential Fatty Acids, vol.44, issue.2, pp.127-131, 1991. ,
DOI : 10.1016/0952-3278(91)90196-C
Different utilization of arachidonic and dihomogammalinolenic acids by human platelet prostaglandin synthetase, Biochimie, vol.59, issue.11-12, pp.935-937, 1977. ,
DOI : 10.1016/S0300-9084(78)80710-X
Manipulation of platelet aggregation by prostaglandins and their fatty acid precursors: Pharmacological basis for a therapeutic approach, Prostaglandins, vol.19, issue.1, pp.165-181, 1980. ,
DOI : 10.1016/0090-6980(80)90163-X
Inhibition of platelet energy production and release reaction by PGE1, theophylline and cAMP, Biochemical and Biophysical Research Communications, vol.41, issue.1, pp.128-134, 1970. ,
DOI : 10.1016/0006-291X(70)90478-X
Thromboxanes: selective biosynthesis and distinct biological properties, Science, vol.193, issue.4248, pp.163-165, 1976. ,
DOI : 10.1126/science.945611
Prostaglandin I3 is formed in vivo in man after dietary eicosapentaenoic acid, Nature, vol.116, issue.5947, pp.165-168, 1984. ,
DOI : 10.1038/307165a0
Triene prostaglandins: Prostaglandin D3 and icosapentaenoic acid as potential antithrombotic substances, Proceedings of the National Academy of Sciences, vol.76, issue.11, pp.5919-5923, 1979. ,
DOI : 10.1073/pnas.76.11.5919
Omega-3 Fatty Acids and Inflammation: Novel Interactions Reveal a New Step in Neutrophil Recruitment, PLoS Biology, vol.45, issue.8, p.1000177, 2009. ,
DOI : 10.1371/journal.pbio.1000177.t003
The Eicosapentaenoic Acid Metabolite 15-Deoxy-??12,14-Prostaglandin J3 Increases Adiponectin Secretion by Adipocytes Partly via a PPAR??-Dependent Mechanism, PLoS ONE, vol.173, issue.5, p.63997, 2013. ,
DOI : 10.1371/journal.pone.0063997.t001
Differential effects of prostaglandin derived from omega-6 and omega-3 polyunsaturated fatty acids on COX ,
16-docosatetraenoic acid to dihomo-thromboxane, 14-hydroxy-7,10,12-nonadecatrienoic acid and hydroxy fatty acids by human platelets, Biochim. Biophys. Acta, vol.1013, issue.833, pp.272-280, 1985. ,
Arachidonate-derived Dihomoprostaglandin Production Observed in Endotoxin-stimulated Macrophage-like Cells, Journal of Biological Chemistry, vol.282, issue.5 ,
DOI : 10.1074/jbc.M610067200
Synthesis of dihomoprostaglandins from adrenic acid (7,10,13,16-docosatetraenoic acid) by human endothelial cells, Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, vol.837, issue.1, pp.67-76, 1985. ,
DOI : 10.1016/0005-2760(85)90086-4
Metabolism of (n-6) and (n-3) polyunsaturated fatty acids by human platelets, Prostaglandins, Leukotrienes and Medicine, vol.23, issue.2-3, pp.129-134, 1986. ,
DOI : 10.1016/0262-1746(86)90175-7
Immunologically induced generation of tetraene and pentaene leukotrienes in the peritoneal cavities of menhaden-fed rats, J ,
Characterization and biologic properties of 5,12-dihydroxy derivatives of eicosapentaenoic acid, including leukotriene B5 and the double lipoxygenase product, J. Biol. Chem, vol.259, pp.2383-2389, 1984. ,
Comparison of the damage-promoting effects of leukotrienes derived from eicosapentaenoic acid and arachidonic acid on the rat stomach, Journal of Experimental Medicine, vol.171, issue.5 ,
DOI : 10.1084/jem.171.5.1827
Synthesis and characterization of cytochrome P-450 epoxygenase metabolites of eicosapentaenoic acid, Lipids, vol.146, issue.8, pp.481-490, 1990. ,
DOI : 10.1007/BF02538092
Resolvins, The Journal of Experimental Medicine, vol.71, issue.8 ,
DOI : 10.1084/jem.183.1.137
Chiral lipidomics of E-series resolvins: Aspirin and the biosynthesis of novel mediators, Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, vol.1811, issue.11, pp.1811-737, 2011. ,
DOI : 10.1016/j.bbalip.2011.06.007
Steric analysis of hydroperoxides formed by lipoxygenase oxygenation of linoleic acid, Analytical Biochemistry, vol.43, issue.2, pp.515-526, 1971. ,
DOI : 10.1016/0003-2697(71)90282-X
13-Hydroxyoctadecadienoic acid is the vessel wall chemorepellant factor, LOX, J. Biol. Chem, vol.260, pp.16056-16059, 1985. ,
Stereochemistry in the formation of [9-hydroxy-10,12-octadecadienoic acid and 13-hydroxy-9,11-octadecadienoic acid from linoleic acid by fatty acid cyclooxygenase, Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, vol.617, issue.3, pp.545-547, 1980. ,
DOI : 10.1016/0005-2760(80)90022-3
Formation of 9-hydroxyoctadecadienoic acid from linoleic acid in endothelial cells, J. Biol. Chem, vol.264, pp.6823-6830, 1989. ,
Glycoxidized HDL, HDL Enriched With Oxidized Phospholipids and HDL From Diabetic Patients Inhibit Platelet Function, The Journal of Clinical Endocrinology & Metabolism, vol.100, issue.5, pp.2006-2014, 2015. ,
DOI : 10.1210/jc.2014-4214
New Developments in α-Linolenate Metabolism with Emphasis on the Importance of β-Oxidation and Carbon Recycling, World Rev. Nutr. Diet, vol.88, pp.178-183, 2001. ,
DOI : 10.1159/000059751
??-Linolenic acid metabolism in men and women: nutritional and biological implications, Current Opinion in Clinical Nutrition and Metabolic Care, vol.7, issue.2, pp.137-144, 2004. ,
DOI : 10.1097/00075197-200403000-00006
Characterization and biological effects of di-hydroxylated compounds deriving from the lipoxygenation of ALA, The Journal of Lipid Research, vol.54, issue.8, pp.2083-2094, 2013. ,
DOI : 10.1194/jlr.M035139
URL : https://hal.archives-ouvertes.fr/inserm-00832286
Stereospecificity of Hydrogen Abstraction in the Conversion of Arachidonic Acid to 15R-HETE by Aspirin-treated Cyclooxygenase-2. IMPLICATIONS FOR THE ALIGNMENT OF SUBSTRATE IN THE ACTIVE SITE, Journal of Biological Chemistry, vol.275, issue.7, pp.4743-4746, 2000. ,
DOI : 10.1074/jbc.275.7.4743
The Significance of cis, cis, cis 5,8,11 Eicosatrienoic Acid in Essential Fatty Acid Deficiency, Nutrition Reviews, vol.38, issue.7, pp.233-235, 1980. ,
DOI : 10.1111/j.1753-4887.1980.tb05910.x
Products derived from 511-eicosatrienoic acid by the 5-lipoxygenaseleukotriene pathway, J. Biol. Chem, vol.8, issue.258, pp.12797-12800, 1983. ,
11-eicosatrienoic acid to leukotrienes C3 and D3, J. Biol. Chem, vol.8, issue.256, pp.2275-2279, 1981. ,
Mechanisms of action of docosahexaenoic acid in the nervous system, Lipids, vol.68, issue.9, pp.945-959, 2001. ,
DOI : 10.1007/s11745-001-0805-6
Substrate and regulatory functions of eicosapentaenoic and docosahexaenoic acids for the 5-lipoxygenase pathway. Implications for pulmonary responses, Prog. Biochem. Pharmacol, vol.20, pp.1-17, 1985. ,
5-Lipoxygenase metabolite 4-HDHA is a mediator of the antiangiogenic effect of ?-3 polyunsaturated fatty acids, Sci. Transl. Med, vol.3, pp.69-81, 2011. ,
Synthesis of hydroxy fatty acids from 4, 7, 10, 13, 16, 19-[1- 14C] docosahexaenoic acid by human platelets, J. Biol. Chem, vol.258, pp.9339-9343, 1983. ,
Full characterization of PDX, a neuroprotectin/protectin D1 isomer, which inhibits blood platelet aggregation, FEBS Letters, vol.94, issue.21, pp.3478-3484, 2009. ,
DOI : 10.1016/j.febslet.2009.10.004
URL : https://hal.archives-ouvertes.fr/inserm-00429322
Endogenous pro-resolving and anti-inflammatory lipid mediators: a new pharmacologic genus, British Journal of Pharmacology, vol.76, issue.69, pp.200-215, 2008. ,
DOI : 10.1038/sj.bjp.0707489
The Lipid Mediator Protectin D1 Inhibits Influenza Virus Replication and Improves Severe Influenza, Cell, vol.153, issue.1, pp.112-125, 2013. ,
DOI : 10.1016/j.cell.2013.02.027
Role of omega-3 PUFA-derived mediators, the protectins, in influenza virus infection, Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, vol.1851, issue.4, pp.496-502, 1851. ,
DOI : 10.1016/j.bbalip.2015.01.006
Protectin DX alleviates insulin resistance by activating a myokine-liver glucoregulatory axis, Nat. Med, vol.20, pp.664-669, 2014. ,
Maresins: novel macrophage mediators with potent antiinflammatory and proresolving actions, The Journal of Experimental Medicine, vol.192, issue.1, pp.15-23, 2009. ,
DOI : 10.1016/S0076-6879(07)32012-0
Maresin Biosynthesis and Identification of Maresin 2, a New Anti-Inflammatory and Pro-Resolving Mediator from Human Macrophages, PLoS ONE, vol.1133, issue.7, 2014. ,
DOI : 10.1371/journal.pone.0102362.s002
The contributions of aspirin and microbial oxygenase to the biosynthesis of anti-inflammatory resolvins: novel oxygenase products from omega-3 ,
Emerging roles of resolvins in the resolution of inflammation and pain, Trends Neurosci, pp.599-609, 2011. ,
Identification and signature profiles for pro-resolving and inflammatory lipid mediators in human tissue, AJP: Cell Physiology, vol.307, issue.1 ,
DOI : 10.1152/ajpcell.00024.2014
Bioacti ve products formed in humans from fish oils, J. Lipid Res, 2015. ,
Studies on platelet lipoxygenase specificity towards icosapolyenoic and docosapolyenoic acids, Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, vol.836, issue.2, pp.210-214, 1985. ,
DOI : 10.1016/0005-2760(85)90068-2
Biogenic Synthesis, Purification, and Chemical Characterization of Anti-inflammatory Resolvins Derived from Docosapentaenoic Acid (DPAn-6), Journal of Biological Chemistry, vol.284, issue.22, pp.14744-14759, 2009. ,
DOI : 10.1074/jbc.M809014200
Novel n-3 Immunoresolvents: Structures and Actions, Scientific Reports, vol.7, 1940. ,
DOI : 10.1038/srep01940
Metabolism and biological production of resolvins derived from docosapentaenoic acid (DPAn-6), Biochemical Pharmacology, vol.79, issue.2, pp.251-260, 2010. ,
DOI : 10.1016/j.bcp.2009.08.001
The biochemistry of the isoprostane, neuroprostane, and isofuran pathways of lipid peroxidation, Chemistry and Physics of Lipids, vol.128, issue.1-2, pp.173-186, 2004. ,
DOI : 10.1016/j.chemphyslip.2003.09.016
Non-enzymatic cyclic oxygenated metabolites of omega-3 polyunsaturated fatty acid: Bioactive drugs?, Biochimie, vol.120, 2015. ,
DOI : 10.1016/j.biochi.2015.06.010
The isoprostanes???25 years later, Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, vol.1851, issue.4, pp.1851-433, 2015. ,
DOI : 10.1016/j.bbalip.2014.10.007
Nonenzymatic cyclic oxygenated metabolites of adrenic, docosahexaenoic, eicosapentaenoic and ?-linolenic acids; bioactivities and potential use as biomarkers ,